Neuroendocrine differentiation is predictive of poor survival in patients with stage II colorectal cancer.
Liu, Yue
Neuroendocrine differentiation is predictive of poor survival in patients with stage II colorectal cancer. [electronic resource] - Oncology letters Apr 2017 - 2230-2236 p. digital
Publication Type: Journal Article
1792-1074
10.3892/ol.2017.5681 doi
Neuroendocrine differentiation is predictive of poor survival in patients with stage II colorectal cancer. [electronic resource] - Oncology letters Apr 2017 - 2230-2236 p. digital
Publication Type: Journal Article
1792-1074
10.3892/ol.2017.5681 doi